| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Research &Development
1 company
Phillips James Michael serves as a SVP, Research &Development at PACB. Across recent SEC filings that breaks down to 1 buy and 7 sells. Those positions are worth an estimated $760K at current prices.
The biggest single holding is PACB (~$760K) as SVP, Research &Development. The recent filings there lean toward selling, a net 89,853 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2020 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sell | 2,760 | $3.05 | $8,420.76 | -1.1% | |
| Feb 20, 2020 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sell | 5,050 | $4.48 | $22,624.00 | -2.0% | |
| Feb 19, 2019 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sell | 7,231 | $7.17 | $51,817.35 | -3.1% | |
| Oct 28, 2016 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sale+OE | 20,000 | $8.44 | $168,720.00 | -9.9% | |
| Jul 29, 2016 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sale+OE | 20,000 | $8.45 | $168,920.00 | -9.9% | |
| Apr 25, 2016 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sale+OE | 20,000 | $10.29 | $205,720.00 | -9.9% | |
| Aug 7, 2015 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Sale+OE | 16,689 | $4.61 | $77,009.72 | -8.5% | |
| Mar 2, 2015 | PACB Pacific Biosciences Of California, Inc. | SVP, Research &Development | Buy | 1,877 | $4.91 | $9,221.70 | +1.2% |